# EDGAR Filing Document

**Accession Number:** 0001498148
**File Stem:** 0001641172-25-019701
**Filing Date:** 2025-7
**Character Count:** 137309
**Document Hash:** 51670547d2d9ee8deb38a0379ba3a24a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-019701.hdr.sgml**: 20250715

**ACCESSION NUMBER**: 0001641172-25-019701

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 79

**CONFORMED PERIOD OF REPORT**: 20250531

**FILED AS OF DATE**: 20250715

**DATE AS OF CHANGE**: 20250715

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Artificial Intelligence Technology Solutions Inc.
- **CENTRAL INDEX KEY:** 0001498148
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 272343603
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0228

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55079
- **FILM NUMBER:** 251124649

**BUSINESS ADDRESS:**
- **STREET 1:** 10800 GALAXIE AVENUE
- **CITY:** FERNDALE
- **STATE:** MI
- **ZIP:** 48220
- **BUSINESS PHONE:** (877) 787-6268

**MAIL ADDRESS:**
- **STREET 1:** 10800 GALAXIE AVENUE
- **CITY:** FERNDALE
- **STATE:** MI
- **ZIP:** 48220

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ON THE MOVE SYSTEMS CORP.
- **DATE OF NAME CHANGE:** 20100803

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-Q**

**☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934**

FOR THE QUARTERLY PERIOD ENDED MAY 31, 2025

OR

**☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934**

FOR THE TRANSITION PERIOD FROM _______________ TO _______________

COMMISSION FILE NUMBER: 000-55079

**<u>ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.</u>**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Nevada** | **27-2343603** |
| (State or other jurisdiction of Incorporation or organization) | (I.R.S. Employer Identification Number) |
| **10800 Galaxie Avenue**<br> **Ferndale, MI** | **48220** |
| (Address of principal executive offices) | (Zip code) |

---

**<u>(877) 787-6268</u>**

(Registrant's telephone number, including area code)

not applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act: **None**

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: 18,297,453,768 shares of common stock were issued and outstanding as of July 11, 2025.

**Table of Contents**

---

| | | |
|:---|:---|:---|
| | | **PAGE** |
| **PART I** | **[FINANCIAL INFORMATION](#ak_001)** |  |
| ITEM 1. | [Financial Statements](#ak_002) | 3 |
|  | [Condensed Consolidated Balance Sheets as of May 31, 2025 and February 28, 2025 (Unaudited)](#ak_003) | 3 |
|  | [Condensed Consolidated Statements of Operations for the Three Months Ended May 31, 2025 and 2024 (Unaudited)](#ak_004) | 4 |
|  | [Condensed Consolidated Statements of Stockholders' Deficit for the Three Months Ended May 31, 2025 and 2024 (Unaudited)](#ak_005) | 5 |
|  | [Condensed Consolidated Statements of Cash Flows for the Three Months Ended May 31, 2025 and 2024 (Unaudited)](#ak_006) | 6 |
|  | [Notes to the Consolidated Financial Statements (Unaudited)](#ak_007) | 7-27 |
| ITEM 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#vv_001) | 28 |
| ITEM 3. | [Quantitative and Qualitative Disclosures About Market Risk](#vv_002) | 32 |
| ITEM 4. | [Controls and Procedures](#vv_003) | 32 |
| **PART II** | **[OTHER INFORMATION](#vv_004)** |  |
| ITEM 1. | [Legal Proceedings](#ak_008) | 33 |
| ITEM 1A. | [Risk Factors](#ak_009) | 33 |
| ITEM 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#vv_005) | 33 |
| ITEM 3. | [Defaults Upon Senior Securities](#vv_006) | 33 |
| ITEM 4. | [Mine Safety Disclosures](#vv_007) | 33 |
| ITEM 5. | [Other Information](#vv_008) | 33 |
| ITEM 6. | [Exhibits](#vv_009) | 34 |
| **[SIGNATURES](#vv_010)** | **[SIGNATURES](#vv_010)** | 35 |

---

[**Table of Contents**](#toc_001)

**PART I – FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS**

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | **May 31, 2025**<br> **(unaudited)** | **February 28,<br> 2025\*** |
| **ASSETS** |  |  |
| **Current assets:** |  |  |
| &nbsp;&nbsp;&nbsp;Cash | $324847 | $865975 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 893694 | 1367331 |
| &nbsp;&nbsp;&nbsp;Share proceeds receivable | 270186 | 418669 |
| &nbsp;&nbsp;&nbsp;Device parts inventory, net | 1146783 | 1583726 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and deposits | 687147 | 792842 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 3322657 | 5028543 |
| &nbsp;&nbsp;&nbsp;Operating lease asset | 1044802 | 1010545 |
| &nbsp;&nbsp;&nbsp;Revenue earning devices, net of accumulated depreciation of $2,744,231 and $2,292,172, respectively | 4982668 | 4539180 |
| &nbsp;&nbsp;&nbsp;Fixed assets, net of accumulated depreciation of $521,203 and $491,186, respectively | 259080 | 258328 |
| &nbsp;&nbsp;&nbsp;Trademarks | 34619 | 33321 |
| &nbsp;&nbsp;&nbsp;Investment at cost | 100000 | 100000 |
| &nbsp;&nbsp;&nbsp;Security deposit | 15880 | 15880 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $9759706 | $10985797 |
| **LIABILITIES AND STOCKHOLDERS' DEFICIT** |  |  |
| **Current liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | $2648311 | $2121871 |
| &nbsp;&nbsp;&nbsp;Customer deposits | 91091 | 91578 |
| &nbsp;&nbsp;&nbsp;Current operating lease liability | 217222 | 197349 |
| &nbsp;&nbsp;&nbsp;Current portion of deferred variable payment obligation | 2202545 | 1901258 |
| &nbsp;&nbsp;&nbsp;Loan payable - related party | 335065 | 329365 |
| &nbsp;&nbsp;&nbsp;Deferred compensation for CEO | 955913 | 2202600 |
| &nbsp;&nbsp;&nbsp;Current portion of loans payable, net | 519105 | 519105 |
| &nbsp;&nbsp;&nbsp;Current portion of accrued interest payable | 107715 | 213555 |
| &nbsp;&nbsp;&nbsp;Total current liabilities | 7076967 | 7576681 |
| &nbsp;&nbsp;&nbsp;Non-current operating lease liability | 810513 | 810513 |
| &nbsp;&nbsp;&nbsp;Loans payable, net of discount of $313,074 and $360,163, respectively | 30706167 | 31922078 |
| &nbsp;&nbsp;&nbsp;Deferred variable payment obligation | 2525000 | 2525000 |
| &nbsp;&nbsp;&nbsp;Incentive compensation plan payable | 4000000 | 4000000 |
| &nbsp;&nbsp;&nbsp;Accrued interest payable | 14741856 | 13680453 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 59860503 | 60514725 |
| Series B Convertible, Redeemable Preferred Stock. $0.001 par value; 8% cumulative dividend payable quarterly,$1,200 stated value, 5,000 shares authorized, no shares issued and outstanding at May 31, 2025 and February 28, 2025, respectively |  |  |
| Series C Convertible, Redeemable Preferred Stock . $0.001 par value; $1,200 stated value, redeemable at 109.5% , 12% dividend, 1,000 shares authorized , 315 and 306 shares issued and outstanding at May 31, 2025 and February 28, 2025, respectively | 414157 | 402084 |
| Commitments and Contingencies |  |  |
| **Stockholders' deficit:** |  |  |
| &nbsp;&nbsp;&nbsp;Preferred Stock, undesignated; 15,534,000 shares authorized; no shares issued and outstanding at May 31, 2025 and February 28, 2025, respectively |  |  |
| &nbsp;&nbsp;&nbsp;Series G Redeemable Preferred Stock. $0.001 par value; 100,000 shares authorized, no shares issued and outstanding at May 31, 2025 and February 28, 2025, respectively |  |  |
| &nbsp;&nbsp;&nbsp;Series E Preferred Stock, $0.001 par value; 4,350,000 shares authorized; 3,350,000 and 3,350,000 shares issued and outstanding, respectively | 3350 | 3350 |
| &nbsp;&nbsp;&nbsp;Series F Convertible Preferred Stock, $1.00 par value; 10,000 shares authorized; 2,513 and 2,513 shares issued and outstanding, respectively | 2513 | 2513 |
| &nbsp;&nbsp;&nbsp;Common Stock, $0.00001 par value; 20,000,000,000 shares authorized 16,997,453,768 and 14,412,453,768 shares issued, issuable and outstanding, respectively | 169975 | 144125 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 110301070 | 106316844 |
| &nbsp;&nbsp;&nbsp;Preferred stock to be issued | 99086 | 99086 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (161090948) | (156496930) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' deficit | (50514954) | (49931012) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' deficit | $9759706 | $10985797 |

---

\* Derived from audited information

***The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.***

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> May 31, 2025** | **Three Months Ended<br> May 31, 2024** |
| **Revenues** | $1854837 | $1182800 |
| Cost of goods sold | 173381 | 295593 |
| Depreciation and amortization | 447955 | 201873 |
| **Total Cost of Goods Sold** | 621336 | 497466 |
| **Gross Profit** | 1233501 | 685334 |
| **Operating expenses:** |  |  |
| &nbsp;&nbsp;&nbsp;Research and development (see Note 10) | 1087619 | 810150 |
| &nbsp;&nbsp;&nbsp;General and administrative | 3232211 | 2550751 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 34121 | 95676 |
| &nbsp;&nbsp;&nbsp;Operating lease cost and rent | 58219 | 62013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 4412170 | 3518590 |
| Loss from operations | (3178669) | (2833256) |
| **Other income (expense), net:** |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense | (1415349) | (1361103) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other income (expense), net | (1415349) | (1361103) |
| **Net income (loss)** | $(4594018) | $(4194359) |
| Net income (loss) per share - basic | $(0.00) | $(0.00) |
| Net income (loss) per share - diluted | $(0.00) | $(0.00) |
| Weighted average common share outstanding - basic | 15517671159 | 9882118105 |
| Weighted average common share outstanding - diluted | 15517671159 | 9882118105 |

---

 ****

***The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.***

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' DEFICIT**

**(Unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Temporary Equity** | **Temporary Equity** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** |
|  | **Series B & C** | **Series B & C** | **Series E** | **Series E** | **Series F** | **Series F** | | | | | |
|  | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Common Stock** | **Common Stock** | | | |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional**<br>**Paid-In**<br>**Capital** |<br>**Accumulated**<br>**Deficit** | **Total**<br>**Shareholders'**<br>**Deficit** |
| **Balance at February 29, 2024** |  |  | 3350000 | $3350 | 2533 | $101619 | 9238750958 | $92388 | $92565513 | $(132962427) | $(40199557) |
| &nbsp;&nbsp;&nbsp;Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024 |  |  |  |  |  |  |  |  |  | (4175535) | (4175535) |
| &nbsp;&nbsp;&nbsp;Issuance of shares, net of $116,046 issuance costs |  |  |  |  |  |  | 1080166425 | 10802 | 2671791 |  | 2682593 |
| &nbsp;&nbsp;&nbsp;Issuance of Series B Preferred Shares | 300 | 360000 |  |  |  |  |  |  | (82000) |  | (82000) |
| &nbsp;&nbsp;&nbsp;Series B Preferred Shares issued as commitment fee | 20 | 24000 |  |  |  |  |  |  | (24000) |  | (24000) |
| &nbsp;&nbsp;&nbsp;Series B Preferred shares issued as dividend | 2 | 2568 |  |  |  |  |  |  | (2568) |  | (2568) |
| &nbsp;&nbsp;&nbsp;Redemption of Series B Preferred shares | (107) | (128856) |  |  |  |  |  |  | 28856 | (28856) |  |
| Stock based compensation |  |  |  |  |  |  |  |  | 83323 |  | 83323 |
| Net income |  |  |  |  |  |  |  |  |  | (4194359) | (4194359) |
| **Balance at May 31, 2024** | 215 | $257712 | 3350000 | $3350 | 2533 | $101619 | 10318917383 | $103190 | $95240915 | $(141361177) | $(45912103) |

---

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Temporary Equity** | **Temporary Equity** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** | **Shareholder's Deficit** |
|  | **Series B & C** | **Series B & C** | **Series E** | **Series E** | **Series F** | **Series F** | | | | | |
|  | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Common Stock** | **Common Stock** | | | |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional**<br>**Paid-In**<br>**Capital** |<br>**Accumulated**<br>**Deficit** | **Total**<br>**Shareholders'**<br>**Deficit** |
| **Balance at February 28, 2025** | 306 | $402084 | 3350000 | $3350 | 2513 | $101599 | 14412453768 | $144125 | $106316844 | $(156496930) | $(49931012) |
| &nbsp;&nbsp;&nbsp;Issuance of shares, net of $121,746 issuance costs |  |  |  |  |  |  | 1900000000 | 19000 | 2672294 |  | 2691294 |
| &nbsp;&nbsp;&nbsp;Debt exchanged for common shares |  |  |  |  |  |  | 685000000 | 6850 | 1243650 |  | 1250500 |
| &nbsp;&nbsp;&nbsp;Series C Preferred shares issued as dividend | 9 | 12073 |  |  |  |  |  |  | (12073) |  | (12073) |
| &nbsp;&nbsp;&nbsp;Stock based compensation |  |  |  |  |  |  |  |  | 80355 |  | 80355 |
| &nbsp;&nbsp;&nbsp;Net income |  |  |  |  |  |  |  |  |  | (4594018) | (4594018) |
| **Balance at May 31, 2025** | 315 | $414157 | 3350000 | $3350 | 2513 | $101599 | 16997453768 | $169975 | $110301070 | $(161090948) | $(50514954) |

---

 ****

***The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.***

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **Three Months<br> Ended<br> May 31, 2025** | **Three Months<br> Ended<br> May 31, 2024** |
| **CASH FLOWS FROM OPERATING ACTIVITIES:** |  |  |
| Net loss | $(4594018) | $(4194359) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 482076 | 297549 |
| &nbsp;&nbsp;&nbsp;Bad debts expense | 48982 | 13000 |
| &nbsp;&nbsp;&nbsp;Inventory provision |  | 210000 |
| &nbsp;&nbsp;&nbsp;Reduction of right of use asset | 33865 | 31425 |
| &nbsp;&nbsp;&nbsp;Accretion of lease liability | 27428 | 31065 |
| &nbsp;&nbsp;&nbsp;Stock based compensation | 80355 | 83323 |
| &nbsp;&nbsp;&nbsp;Amortization of debt discounts | 47089 | 27625 |
| &nbsp;&nbsp;&nbsp;Increase in related party accrued payroll and interest | 5700 | 17575 |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 424655 | 126620 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and deposits on inventory | 104498 | 167562 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deposit on right of use asset | (13187) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Device parts inventory | (480951) | (1070087) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 524109 | (21083) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customer deposits | (487) | (11469) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liability payments | (58962) | (58715) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred compensation for CFO | (1246687) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of deferred variable payment obligations for payments | 301287 | 192323 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued interest payable | 993063 | 1111815 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (3321185) | (3045831) |
| **CASH FLOWS FROM INVESTING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of fixed assets | (8422) | (19132) |
| &nbsp;&nbsp;&nbsp;Acquisition of trademarks | (1298) | (2596) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) investing activities | (9720) | (21728) |
| **CASH FLOWS FROM FINANCING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;Share proceeds net of issuance costs | 2839777 | 2682592 |
| &nbsp;&nbsp;&nbsp;Proceeds on issuance of Series B shares |  | 278000 |
| &nbsp;&nbsp;&nbsp;Redemption of Series B shares |  | (128856) |
| &nbsp;&nbsp;&nbsp;Proceeds from loans payable |  | 350000 |
| &nbsp;&nbsp;&nbsp;Repayment of loans payable | (50000) | (27000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 2789777 | 3154736 |
| Net change in cash | (541128) | 87177 |
| Cash, beginning of period | 865975 | 105926 |
| Cash, end of period | $324847 | $193103 |
| Supplemental disclosure of cash and non-cash transactions: |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | $8910 | $25015 |
| &nbsp;&nbsp;&nbsp;Cash paid for income taxes | $— | $— |
| &nbsp;&nbsp;&nbsp;Noncash investing and financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Transfer from device parts inventory to fixed assets and revenue earning devices | $917294 | $1161219 |
| &nbsp;&nbsp;&nbsp;Exchange of notes payable and accrued interest for common shares | $1250500 | $— |
| &nbsp;&nbsp;&nbsp;Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024 | $— | $4175535 |
| &nbsp;&nbsp;&nbsp;Series B or C preferred shares issued as dividend | $12073 | $2568 |
| &nbsp;&nbsp;&nbsp;Right of use asset for lease liability | $53739 | $— |

---

***The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.***

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**1. GENERAL INFORMATION**

Artificial Intelligence Technology Solutions Inc. ("AITX" or the "Company") was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp ("OMVS").

Robotic Assistance Devices, LLC ("RAD"), was incorporated in the State of Nevada on July 26, 2016 as a Limited Liability Company. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 common shares to its sole shareholder.

On August 28, 2017, AITX completed the acquisition of RAD (the "Acquisition"), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX's prior business focus was transportation services, and was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, and AITX's business going forward will consist of one segment activity, which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.

The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX's operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

**2. GOING CONCERN**

The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

For the three months ended May 31, 2025, the Company had negative cash flow from operating activities of $3,321,185. As of May 31, 2025, the Company has an accumulated deficit of $161,090,948, and negative working capital of $3,754,310. Management does not anticipate having positive cash flow from operations in the near future. These factors raise a substantial doubt about the Company's ability to continue as a going concern for the twelve months following the issuance of these financial statements.

The Company does not have the resources at this time to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company's financial situation as follows:

Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In June 2025, the Company entered into an equity financing agreement whereby an investor will purchase up to $30,000,000 of the Company's common stock at a discount over a two-year period. There still remains $30 million left to issue under this arrangement. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways: growing revenues, through equity proceeds, and issuing non-convertible debt. Management has had many recent conversations with the Company's primary debt holder and believes that the non-convertible debt on the balance sheet will be extended. Management notes that non-convertible debt on the books has been extended by this debt holder twice in the past and notes that this debt holder has been a strong supporter of the Company.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**3. ACCOUNTING POLICIES**

***Basis of Presentation and Consolidation***

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the audited financial statements and notes thereto in the Company's latest Annual Report filed with the SEC on Form 10-K as filed on May 29, 2025. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., and Robotic Assistance Devices Residential, Inc., and Robotic Assistance Devices Lanka (Private) Limited. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the three months ended May 31, 2025, are not necessarily indicative of the results that may be expected for the entire year.

***Use of Estimates***

In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value equity instruments used in debt settlements, amendments and extensions.

***Reclassifications***

Certain amounts in the Company's consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.

***Concentrations***

*Loans payable* 

At May 31, 2025 there were $31,538,346 of loans payable, $27,393,506 or 87% of these loans to companies controlled by one individual. At February 28, 2025 there were $32,801,345 loans payable, $28,581,506 or 87% of these loans to companies controlled by one individual.

***Cash***

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.

***Accounts Receivable***

Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $115,000 and $140,000 provided as of May 31, 2025 and February 28, 2025, respectively. For the three months ended May 31, 2025, three customers account for 53% of total accounts receivable . For the three months ended May 31, 2024, two customers account for 57% of total accounts receivable.

***Device Parts Inventory***

Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of May 31, 2025, and February 28, 2025, there was a valuation reserve of $465,000 and $465,000, respectively.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

***Revenue Earning Devices***

Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.

***Fixed Assets***

Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.

---

| | |
|:---|:---|
| Computer equipment and software | 2 or 3 years |
| Office equipment | 4 years |
| Manufacturing equipment | 7 years |
| Warehouse equipment | 5 years |
| Tooling | 2 years |
| Demo Devices | 4 years |
| Vehicles | 3 years |
| Leasehold improvements | 5 years, the life of the lease |

---

The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.

***Research and Development***

Research and development costs are expensed in the period they are incurred in accordance with ASC 730, *Research and Development* unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At May 31, 2025 and February 28, 2025, the Company had no deferred development costs.

***Contingencies***

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company's consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

***Sales of Future Revenues***

The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

● Does the agreement purport, in substance, to be a sale

● Does the Company have continuing involvement in the generation of cash flows due to the investor

● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets

● Is the investors rate of return is implicitly limited by the terms of the agreement

● Does the Company's revenue for a reporting period underlying the agreement have only a minimal impact on the investor's rate of return

● Does the investor have recourse relating to payments due

In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.

***Revenue Recognition***

ASU 2014-09, *"Revenue from Contracts with Customers (Topic 606)"*, supersedes the revenue recognition requirements and industry specific guidance under *Revenue Recognition (Topic 605)*. Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America ("U.S. GAAP") including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the three months ended May 31, 2025, two customers accounted for 65% of total revenue and for the three months ended May 31, 2024, two customers accounted for 65% of total revenue.

***Income Taxes***

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

On December 22, 2017, the Tax Cuts and Jobs Act ("Tax Act") was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company's gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company's net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company's financial results, including disclosures, for the Company's fiscal year ending February 28, 2026, but the Company does not expect the Tax Act to have a material impact on the Company's consolidated financial statements.

***Leases***

Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.

Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.

***Distinguishing Liabilities from Equity***

The Company relies on the guidance provided by ASC Topic 480, *Distinguishing Liabilities from Equity*, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet ("temporary equity"). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

Our Chief Executive Officer/ Chairman holds sufficient shares of the Company's voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

*Initial Measurement*

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

*Subsequent Measurement – Financial Instruments Classified as Liabilities*

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

***Fair Value of Financial Instruments***

ASC Topic 820, *Fair Value Measurements and Disclosures* ("ASC Topic 820") provides a framework for measuring fair value in accordance with generally accepted accounting principles.

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

● Level 3 – Inputs that are unobservable for the asset or liability.

 

*Measured on a Recurring Basis*

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | | **Fair Value Measurement Using** | **Fair Value Measurement Using** | **Fair Value Measurement Using** |
|  | **Amount at**<br>**Fair Value** | **Level 1** | **Level 2** | **Level 3** |
| **May 31, 2025** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**Assets** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**Investment at cost** | $100000 | $50000 | $— | $50000 |
| &nbsp;&nbsp;&nbsp;**Liabilities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incentive compensation plan payable – revaluation of equity awards payable in Series G shares | $4000000 | $— | $— | $4000000 |
| **February 28, 2025** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**Assets** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**Investment at cost** | $100000 | $50000 | $— | $50000 |
| &nbsp;&nbsp;&nbsp;**Liabilities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incentive compensation plan payable – revaluation of equity awards payable in Series G shares | $4000000 | $— | $— | $4000000 |

---

For the incentive compensation plan referred to above , the Company recorded stock based compensation of $0 and $0 for the three months ended May 31, 2025 and May 31, 2024 with corresponding adjustments to incentive compensation plan payable.

The carrying amounts of the Company's financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.

***Earnings (Loss) per Share***

Basic earnings (loss) per share ("EPS") is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.

Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**4. REVENUE FROM CONTRACTS WITH CUSTOMERS**

Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).

As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company's method of adoption and the impact on the Company's financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.

After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.

The following table presents revenues from contracts with customers disaggregated by product/service:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> May 31, 2025** | **Three Months Ended<br> May 31, 2024** |
| Device rental activities | $1627286 | $980536 |
| Direct sales of goods and services | 227551 | 202264 |
|  | $1854837 | $1182800 |

---

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**5. LEASES**

We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.

There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.

Below is a summary of our lease assets and liabilities at May 31, 2025 and February 28, 2025.

---

| | | | |
|:---|:---|:---|:---|
| **Leases** | **Classification** | **May 31, 2025** | **February 28, 2025** |
| **Assets** |  |  |  |
| Operating | Operating Lease Assets | $1044802 | $1010545 |
| **Liabilities** |  |  |  |
| Current |  |  |  |
| Operating | Current Operating Lease Liability | $217222 | $197349 |
| Noncurrent |  |  |  |
| Operating | Noncurrent Operating Lease Liabilities | 810513 | 810513 |
| Total lease liabilities |  | $1027735 | $1007862 |

---

Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.

Operating lease cost and rent was $58,219 and $62,013 for the three months ended May 31, 2025 and May 31, 2024, respectively.

**6. INVESTMENT**

On December 23, 2022 the Company entered into a Simple Agreement for Future Equity (SAFE) contract to invest $50,000 to acquire shares of a company's capital stock at a discount. On June 3, 2024 the Company acquired a $50,000 convertible note receivable from Nightingale Intelligent Systems, Inc., a private Delaware corporation that provides unmanned aerial vehicles (UAV) for commercial applications. On January 3, 2025 the Company exchanged it's convertible note receivable for : 1,770,840 Series A preferred shares , 15,000 common shares and 165,000 common share warrants. On February 28, 2025, there was a 10 :1 split. The Company now holds 177,084 Series A preferred shares , 1,500 common shares and 16,500 common share warrants (at a strike price of $0.80/share). The Company values the Nightingale Intelligent Systems, Inc.'s shares and warrants at $50,000 bringing total investments at cost to $100,000 at May 31, 2025.

**7. REVENUE EARNING DEVICES**

Revenue earning devices consisted of the following:

---

| | | |
|:---|:---|:---|
|  | **May 31, 2025** | **February 28, 2025** |
| Revenue earning devices | $7726899 | $6831352 |
| Less: Accumulated depreciation | (2744231) | (2292172) |
|  | $4982668 | $4539180 |

---

During the three months ended May 31, 2025, the Company made total additions to revenue earning devices of $895,547 which were transfers from inventory. During the three months ended May 31, 2024, the Company made total additions to revenue earning devices of $1,128,175 which were transfers from inventory

Depreciation and amortization for the years ended May 31, 2025, and May 31, 2024, are as follows:

---

| | | |
|:---|:---|:---|
| **Depreciation and Amortization RED** | **Three Months Ended** <br> **May 31 2025** | **Three Months Ended <br> May 31, 2024** |
| Cost of Goods Sold | $447955 | $201873 |
| Operating expenses | 4104 | 54355 |
| Total Depreciation and Amortization RED | $452059 | $256228 |

---

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**8. FIXED ASSETS**

Fixed assets consisted of the following:

---

| | | |
|:---|:---|:---|
|  | **May 31, 2025** | **February 28, 2025** |
| Automobile | $74237 | $74237 |
| Demo devices | 324533 | 302186 |
| Tooling | 107020 | 107020 |
| Machinery and equipment | 17247 | 8825 |
| Computer equipment | 157448 | 157448 |
| Office equipment | 15312 | 15312 |
| Furniture and fixtures | 21225 | 21225 |
| Warehouse equipment | 36305 | 36305 |
| Leasehold improvements | 26956 | 26956 |
|  | 780283 | 749514 |
| Less: Accumulated depreciation | (521203) | (491186) |
|  | $259080 | $258328 |

---

During the three months ended May 31, 2025, the Company made additions of $46,071 of which $22,347 were transfers from inventory with remaining additions of $23,724. During the three months ended May 31, 2024, the Company made additions of $52,177 of which $33,045 were transfers from inventory with remaining additions of $19,132.

Depreciation and amortization for the years ended May 31, 2025, and May 31, 2024, are as follows:

---

| | | |
|:---|:---|:---|
| **Depreciation and Amortization** | **Three Months Ended** <br> **May 31 2025** | **Three Months Ended <br> May 31, 2024** |
| Fixed assets | $30017 | $41321 |
| Revenue earning devices | 4104 | 54355 |
| Total Depreciation and Amortization included in operating expenses | $34121 | $95676 |

---

**9. DEFERRED VARIABLE PAYMENT OBLIGATION**

On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company's reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.

On May 9, 2019 the Company entered into two similar arrangements with two investors:

&nbsp;&nbsp;&nbsp;&nbsp;(1) The
 investor would pay up to $400,000 in exchange for a perpetual 4 % rate Payment on the Company's reported quarterly Revenues.
 At February 29, 2020, $400,000 has been paid to the Company.

(2) The
 investor would pay up to $50,000 in exchange for a perpetual 1.11 % rate Payment on the Company's reported quarterly Revenues.
 At February 29, 2020, $50,000 has been paid to the Company.

These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD's available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.

In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

On November 18, 2019, the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company's quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020, the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.

On December 30, 2019, the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company's quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020, the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.

On April 22, 2020, the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company's quarterly Revenues. At May 31, 2020, the investor has fully funded this commitment.

On July 1, 2020, the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company's reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD's available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.

On August 27, 2020, the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020. Upon an event of default that we are unable to cure in the time allotted under the agreements, these Payments may be secured with a priority lien by UCC filing against all of our assets, but is subordinated to equipment financing or leasing agreements on the products the Company leases to its customers.

In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%.

The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and accrue every quarter thereafter. As of May 31, 2025, the Company has accrued $2,202,545 in Payments of which $1,096,700 are in arrears. As of February 28, 2025, the Company has accrued approximately $1,901,258 in Payments, of which $904,377 is in arrears. No notices have been received by the Company.

On March 1, 2021, the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:

1) The rate payment was reduced from 14.25 % to 9.65 %

2) The asset disposition % (see below) was reduced from 31 % to 21%

In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five-year term and an exercise price of $1.00. During the three months ended May 31, 2021, the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The Company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of May 31, 2025, and February 28, 2025, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.

For both the three months ended May 31, 2025, and year ended February 28, 2025, the Company has received $0 related to the deferred payment obligation since there were no new agreements during this period. The balance remains $2,525,000 at both May 31, 2025 and February 28, 2025.

**10. RELATED PARTY TRANSACTIONS**

For both the three months ended May 31, 2025, and May 31, 2024, the Company had no repayments of net advances from its loan payable-related party. At May 31, 2025, the loan payable-related party was $335,065 and $329,365 at February 28, 2025. Included in the balance due to the related party at May 31, 2025, is $258,533 of deferred salary and interest, $190,013 of which bears interest at 12%. As of February 28, 2025, included in the balance due to the related party is $252,833 of deferred salary and interest, $190,013 of which bears interest at 12%. The accrued interest included in the loan at May 31, 2025, and February 28, 2025, was $57,275, and $51,575, respectively.

During the three months ended May 31, 2025, the Company paid out gross payments to the CEO of $1,496,687 offset by a bonus accrual of $250,000, which yields a net change of $1,246,687 relating to deferred compensation for CEO. This was all in accordance with a December 2023 board action allowing for $1 million of annual discretionary compensation as well as a February 28, 2025, board action which provided an additional $1.5 million in compensation. There were no payments or accruals for the three months ended May 31, 2025, relating to deferred compensation for CEO. The balance of deferred compensation for CEO was $955,913 and $2,202,600 at May 31, 2025, and February 28, 2025, respectively

For the three months ended May 31, 2025, the Company accrued $0 (three months ended May 31 2024-$0) of incentive compensation plan payable to the CEO . This will be payable in Series G Preferred Shares which are redeemable at the Company's option at $1,000 per share. At May 31, 2025, and February 28, 2025, there was $4,000,000 and $4,000,000 of incentive compensation payable.

During the three months ended May 31, 2025, and 2024, the Company was charged $736,875 and $631,584, respectively for fees for research and development from a company partially owned by a principal shareholder. The principal shareholder received no compensation from this partially owned research and development company and the fees were spent on core development projects. As at both May 31, 2025, and February 28, 2025, the balance due to this company was $76,532.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**11. LOANS PAYABLE**

Loans payable at May 31, 2025 consisted of the following:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Date** | **Maturity** | **Description** |  | **Principal** | **Interest Rate** |
| July 18, 2016 | July 18, 2017 | Promissory note | (1)\* | $3500 | 22% |
| December 10, 2020 | March 1, 2027 | Promissory note | (2) | 3921168 | 12% |
| December 10, 2020 | March 1, 2027 | Promissory note | (3) | 2754338 | 12% |
| December 10, 2020 | December 10, 2024 | Promissory note | (4)\* | 165605 | 12% |
| December 14, 2020 | March 1, 2027 | Promissory note | (5) | 310375 | 12% |
| December 30, 2020 | March 1, 2027 | Promissory note | (6) | 350000 | 12% |
| January 1, 2021 | March 1, 2027 | Promissory note | (7) | 25000 | 12% |
| January 1, 2021 | March 1, 2027 | Promissory note | (8) | 145000 | 12% |
| January 14, 2021 | March 1, 2027 | Promissory note | (9) |  | 12% |
| February 22, 2021 | March 1, 2027 | Promissory note | (10) | 1650000 | 12% |
| March 1, 2021 | March 1, 2027 | Promissory note | (11) | 5175000 | 12% |
| June 8, 2021 | June 8, 2027 | Promissory note | (12) | 2750000 | 12% |
| July 12, 2021 | July 26, 2026 | Promissory note | (13) | 3690360 | 7% |
| September 14, 2021 | September 14, 2027 | Promissory note | (14) | 1650000 | 12% |
| July 28, 2022 | March 1, 2027 | Promissory note | (15) | 170000 | 15% |
| August 30, 2022 | August 30, 2027 | Promissory note | (16) | 3000000 | 15% |
| September 7, 2022 | March 1, 2027 | Promissory note | (17) | 400000 | 15% |
| September 8, 2022 | March 1, 2027 | Promissory note | (18) | 475000 | 15% |
| October 13, 2022 | March 1, 2027 | Promissory note | (19) | 350000 | 15% |
| October 28, 2022 | October 31, 2026 | Promissory note | (20) | 400000 | 15% |
| November 9, 2022 | October 31, 2026 | Promissory note | (20) | 400000 | 15% |
| November 10, 2022 | October 31, 2026 | Promissory note | (20) | 400000 | 15% |
| November 15, 2022 | October 31, 2026 | Promissory note | (20) | 400000 | 15% |
| January 11, 2023 | October 31, 2026 | Promissory note | (20) | 400000 | 15% |
| February 6, 2023 | October 31, 2026 | Promissory note | (20) | 400000 | 15% |
| April 5. 2023 | October 31, 2026 | Promissory note | (20) | 400000 | 15% |
| April 20, 23 | October 31, 2026 | Promissory note | (20) | 400000 | 15% |
| May 11, 2023 | October 31, 2026 | Promissory note | (20) | 400000 | 15% |
| October 27, 2023 | October 31, 2026 | Promissory note | (20) | 400000 | 15% |
| November 30, 2023 | April 30, 2026 | Purchase Agreement | (21) | 203000 | 35% |
| March 8, 2024 | August 8, 2025 | Purchase Agreement | (22) | 350000 | 35% |
|  |  |  |  | $31538346 |  |
| Less: current portion of loans payable | Less: current portion of loans payable | Less: current portion of loans payable |  | (519105) |  |
| Less: discount on non-current loans payable | Less: discount on non-current loans payable | Less: discount on non-current loans payable |  | (313074) |  |
| Non-current loans payable, net of discount | Non-current loans payable, net of discount | Non-current loans payable, net of discount |  | $30706167 |  |
| Current portion of loans payable | Current portion of loans payable | Current portion of loans payable |  | $519105 |  |
| Less: discount on current portion of loans payable | Less: discount on current portion of loans payable | Less: discount on current portion of loans payable |  | - |  |
| Current portion of loans payable, net of discount | Current portion of loans payable, net of discount | Current portion of loans payable, net of discount |  | $519105 |  |

---

\* In default

On March 1, 2024 the Company adjusted the relative fair value unamortized discount on the above notes by $4,175,535 with a corresponding adjustment to accumulated deficit to apply ASU 2020-06.

(1) This
 note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed
 on the lender.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

(2) This
 promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of
 $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168 , and a warrant to purchase 450,000,000 shares
 at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000 . This note is secured
 by a general security charging all of the Company's present and after-acquired property. On November 28, 2023, the parties
 extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April
 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions
 remaining the same.

(3) This
 promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of
 $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338 , and a warrant to purchase 250,000,000 shares
 at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000 . This note is secured
 by a general security charging all of the Company's present and after-acquired property. $300,000 has been repaid during the
 year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025,
 with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March
 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

(4) This
 promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of
 $62,425 totaling $165,605 was exchanged for this promissory note of $165,605 , and a warrant to purchase 80,000,000 shares at an exercise
 price of $.002 per share and a three-year maturity having a fair value of $176,000 . The maturity date was extended from December 10,
 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense. The note is in default.
 No notices have been sent.

(5) This
 promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of
 $75,375 totaling $310,375 was exchanged for this promissory note of $310,375 , and a warrant to purchase 25,000,000 shares at an exercise
 price of $.002 per share and a three-year maturity having a fair value of $182,500 .

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

(6) The
 note, with an original principal amount of $350,000 , may be pre-payable at any time. The note balance includes an original issue
 discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3 -year
 term and having a relative fair value of $271,250 . The discounts are being amortized over the term of the loan. After allocating
 these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment
 to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of
 $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28,
 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining
 the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms
 and conditions remaining the same. For the three months ended May 31, 2025 , the Company recorded amortization expense of $138 , with
 an unamortized discount of $0 at May 31, 2025.The loan is fully amortized.

(7) This
 promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000 . This note is secured by a general security charging all of the
 Company's present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1,
 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the
 maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

(8) This
 promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000 . This note is secured by a general security charging all of
 the Company's present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January
 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended
 the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

(9) The
 note, with an original principal amount of $550,000 , may be pre-payable at any time. The note balance includes an original issue
 discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3 -year term and having a relative fair value of $380,174 . The discounts are being amortized over the term of the loan. After allocating
 these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment
 to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment
 to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from
 January 14, 2024, to March 1, 2025, with all other terms and Conditions remaining the same. On April 16, 2025, the parties again
 extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the
 three months ended May 31, 2025 , the Company recorded amortization expense of $144 , with an unamortized discount of $0 at May 31,
 2025. The loan is fully amortized. On February 11, 2025, the Company repaid $162,000 through the issuance of 60,000,000 common
 shares. The remaining $388,000 in loan principal as well as $35,500 in accrued interest (all totaling $425,500) was repaid
 on March 5, 2025 through the issuance of 185,000,000 common shares.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

(10) The
 note, with an original principal balance of $1,650,000 , may be pre-payable at any time. The note balance includes an original issue
 discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3 -year term and having a relative fair value of $1,342,857 . The discount and warrant are being amortized over the term of the loan.
 After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding
 adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022,
 to February 22, 2024, on February 28, 2022, in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3 -year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in
 capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February
 22, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair
 value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions
 remaining the same. For the three months ended May 31, 2025, the Company recorded amortization expense of $700 , with an unamortized
 discount of $0 at May 31, 2025. The loan is fully amortized.

(11) The
 unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes
 an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3 -year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note
 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their
 respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the
 warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This
 note has been fully amortized. This note was again extended to March 1, 2025. On April 16, 2025, the parties again extended the maturity
 date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the three months ended May
 31, 2025 , the Company has issued 500,000,000 common shares to repay $825,000 in loan principal.

(12) The
 note, with an original principal balance of $2,750,000 , may be pre-payable at any time. The note balance includes an original issue
 discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3 -year term and having a relative fair value of $2,035,033 . The discounts are being amortized over the term of the loan. After allocating
 these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment
 to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants
 to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded
 as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was
 extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding
 adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded
 amortization expense of $964 , with an unamortized discount of $0 at May 31, 2025. The loan is fully amortized On April 16,
 2025, the parties again extended the maturity date from June 8, 2025, to June 8, 2027, with all other terms and conditions remaining
 the same.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

(13) This
 loan, with an original principal balance of $4,000,160 , was in exchange for 184 Series F preferred shares from a former director.
 The interest and principal are payable at maturity. The loan is unsecured. During the three months ended May 31, 2025
 the Company repaid $50,000 as part of a settlement with the estate of the lender . A settlement agreement was entered into on April
 25, 2025 between the Company and the Estate of the lender whereby the Company would repay a total of $420,000 to fully discharge the
 outstanding loan balance and accrued interest which totals $4,790,185 . The Company was required to pay $50,000 in trust , which it
 did with the remainder to be repaid by July 9, 2025. This settlement agreement was subject to court approval which was granted on
 June 5, 2025. The Company and the estate of the lender have modified the remaining payment schedule. The Company repaid $150,000 in June and will repay the $220,000 remaining balance by August 9, 2025. At May 31, 2025 the outstanding principal and interest was
 $4,740,185 . Upon settlement in August , the Company will record a gain on settlement of debt of $4,370,185 .

(14) The
 note, with an original principal balance of $1,650,000 , may be pre-payable at any time. The note balance includes an original issue
 discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3 -year term and having a relative fair value of $1,284,783 , The discounts are being amortized over the term of the loan. After allocating
 these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment
 to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment
 to accumulated deficit. A $66,846 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded amortization
 expense of $1,935 , with an unamortized discount of $23,246 at May 31, 2025. On April 16, 2025, the parties again extended the maturity
 date from September 14, 2025, to September 14, 2027, with all other terms and conditions remaining the same.

(15) Original
 $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000 . Principal and interest
 due at maturity. Secured by a general security charging all of RAD's present and after-acquired property. On November 29, 2023,
 the parties extended the maturity date from July 28, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March
 1, 2027, with all other terms and conditions remaining the same.

(16) A
 warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000 , bearing interest at 15 % with a two year maturity.
 The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount
 of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized
 relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully
 amortized. This note was extended to August 30, 2025. On April 16, 2025, the parties again extended the maturity date from August
 30, 2025, to August 30, 2027, with all other terms and conditions remaining the same.

(17) Original
 $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000 . Principal and interest
 due at maturity. Secured by a general security charging all of RAD's present and after-acquired property. On November 29, 2023,
 the parties extended the maturity date from September 7, 2023, to March 1, 2025, with all other terms and conditions remaining the
 same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to
 March 1, 2027, with all other terms and conditions remaining the same.

(18) Original
 $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000 . Principal and interest
 due at maturity. Secured by a general security charging all of RAD's present and after-acquired property. On November 29, 2023,
 the parties extended the maturity date from September 8, 2023, to March 1, 2025, with all other terms and conditions remaining the
 same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to
 March 1, 2027, with all other terms and conditions remaining the same.

(19) Original
 $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000 . Principal and interest
 due at maturity. Secured by a general security charging all of the Company's present and after-acquired property. On November
 29, 2023, the parties extended the maturity date from October 13, 2023, to March 1, 2025, with all other terms and conditions remaining
 the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025,
 to March 1, 2027, with all other terms and conditions remaining the same.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

---

| | |
|:---|:---|
| (20) | On October 28, 2022, the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company's present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $4,000,000 as follows: |
|  | October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded amortization expense of $4,272, with an unamortized discount of $28,638 at May 31, 2025. |

---

(20) November
 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of
 $299,750 . On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment
 to accumulated deficit. A $48,126 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded amortization
 expense of $4,293 , with an unamortized discount of $28,783 at May 31, 2025.

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded amortization expense of $4,307, with an unamortized discount of $28,885 at May 31, 2025.

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded amortization expense of $4,280, with an unamortized discount of $28,691 at May 31, 2025.

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded amortization expense of $4,293, with an unamortized discount of $28,783 at May 31, 2025.

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded amortization expense of $4,307, with an unamortized discount of $28,888 at May 31, 2025.

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded amortization expense of $4,317, with an unamortized discount of $28,959 at May 31, 2025.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded amortization expense of $4,349, with an unamortized discount of $29,186 at May 31, 2025.

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded amortization expense of $4,454, with an unamortized discount of $29,930 at May 31, 2025.

October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the three months ended May 31, 2025, the Company recorded amortization expense of $4,335, with an unamortized discount of $29,083 at May 31, 2025.

(21) On
 November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen
 future monthly payments of $36,750 commencing on April 30, 2024 through to April 30, 2025 totaling $477,750 . The effective interest
 rate is 35 % per annum. Secured by a general security charging all of RAD's present and after-acquired property. Default rate
 of 15 % per annum calculated daily on any missed monthly payment. The Company has repaid $147,000 and $53,000 in accrued interest
 in July to account for the missed April through to August 2024 payments in agreement with the lender. The Company have missed the
 subsequent monthly payments. On April 16, 2025, the parties again extended the maturity date from April 30, 2025, to April 30, 2026,
 with all other terms and conditions remaining the same.

(22) On
 March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen
 future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750 . The effective interest
 rate is 35 % per annum. Secured by a general security charging all of RAD's present and after- acquired property. Default rate
 of 15 % per annum calculated daily on any missed monthly payment. The August 2024 through to May 2025 payments have not been made
 but will be resolved with the lender. No notices have been sent.

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**12. STOCKHOLDERS' EQUITY (DEFICIT)**

***Summary or Preferred Stock Activity***

**Series C Convertible, Redeemable Preferred Stock (Temporary Equity)**

On February 10, 2025, in connection with a Share Purchase Agreement the Company created a new class of Series C Convertible Redeemable with 1,000 authorized shares.

In exchange for 306 Series C Convertible Redeemable Preferred Shares , the Company received gross proceeds of $306,000 with net proceeds of $278,580 after paying $6,000 in legal fees and $21,420 in broker fees both charged against paid in capital. The Company must redeem the shares at stated capital of 1,200 per share and a 1.09 premium at 180 days after issuance. The Company recorded the 306 outstanding shares at its redemption value of $402,084 at February 28, 2025, with the offsetting adjustment to paid in capital. On May 10, 2025 the Company issued the 12% quarterly dividend in 9.19 Series C shares with a redemption value of $12,073. At May 31, 2025 there were 315 outstanding series C shares with a redemption value of $414,157. Ay February 28, 2025 there were 306 outstanding series C shares with a redemption value of $402,084.

**Series F Convertible Preferred Stock**

Each holder of Series F Convertible Preferred Shares may, at any time and from time to time convert all, but not less than all, of their shares into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion by three and 45 100ths (3.45) on a pro rata basis.

***Summary of Preferred Stock Warrant Activity***

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of Series F Preferred Warrants** | **Weighted**<br> **Average Exercise Price** | **Weighted**<br> **Average Remaining Years** |
| Outstanding at February 28, 2025 | 939 | $1.00 | 8.5 |
| Issued |  |  |  |
| Exercised |  |  |  |
| Forfeited and cancelled |  |  |  |
| Outstanding at May 31, 2025 | 939 | $1.00 | 8.25 |

---

***Summary of Common Stock Activity***

For the three months ended May 31, 2025:

- the Company issued 1,900,000,000 common shares with gross proceeds of $2,813,040 and net proceeds of $2,691,294 after issuance costs of $121,746. Included in the net proceeds are $270,186 in share proceeds receivable received after quarter year end.

- the Company issued 685,000,000 common shares to repay $1,213,000 in loans payable and $37,500 in accrued interest all totaling $1,250,500.

 ****

***Summary of Common Stock Warrant Activity***

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded a total of $80,355 and $83,323 respectively, to stock-based compensation for options and warrants with a corresponding adjustment to additional paid-in capital.

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of<br> Warrants** | **Weighted Average<br> Exercise Price** | **Weighted Average<br> Remaining Years** |
| Outstanding at February 28, 2025 | 41271449 | $0.003 | 2.44 |
| Issued |  |  |  |
| Exercised |  |  |  |
| Forfeited and cancelled |  |  |  |
| Outstanding at May 31, 2025 | 47271449 | $0.001 | 2.18 |

---

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

***Summary of Common Stock Option Activity -Employee Stock Options***

SUMMARY OF COMMON STOCK OPTION ACTIVITY

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of Options** | **Weighted Average Exercise Price** | **Weighted Average Remaining Years** |
| Outstanding at March 1, 2025 | 182228131 | $0.02 | 3.10 |
| Issued |  |  |  |
| Exercised |  |  |  |
| Forfeited, extinguished and cancelled | (3322058) | $0.02 | (2.99) |
| Outstanding at May 31, 2025 | 178906073 | $0.02 | 2.85 |

---

**13. COMMITMENTS AND CONTINGENCIES**

***Litigation***

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company's condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

The related legal costs are expensed as incurred.

 ****

On September 24, 2024, a prospective lender filed a claim against the Company for an alleged breach of a non-binding term sheet made on June 7, 2024. The Company and its counsel believe the claim is without merit however the courts have mandated mediation. After consideration of business factors the parties executed a settlement agreement in June 2025 with the Company agreeing to pay $65,000 with no admission of wrongdoing. The Company accrued the $65,000 at May 31, 2025.

 ****

***Operating Lease***

On March 10, 2021, the Company entered into a 10 year lease agreement for a manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.

On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month. The Company paid a down payment of $9,357.

On March 11, 2025, the Company entered into a 3-year lease agreement for a vehicle commencing March 11, 2025 through to March 11, 2028 with a minimum base rent of $1,286 per month. The Company paid a down payment of $13,188. The Company recorded the right of use asset of $53,739 with a corresponding adjustment to operating lease liability.

The Company's leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $58,219 and $62,013 for the three months ended May 31, 2025 and May 31, 2024, respectively.

---

| | |
|:---|:---|
| **Maturity of Lease Liabilities** | **Operating<br> Leases** |
| May 31, 2026 | $245173 |
| May 31, 2027 | 239242 |
| May 31, 2028 | 222427 |
| May 31, 2029 | 207558 |
| May 31, 2030 | 207558 |
| May 31, 2031 and after | 190262 |
| Total lease payments | 1312220 |
| Less: Interest | (284485) |
| Present value of lease liabilities | $1027735 |

---

[**Table of Contents**](#toc_001)

**ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**14. EARNINGS (LOSS) PER SHARE**

The net income (loss) per common share amounts were determined as follows:

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** |
|  | **May 31, 2025** | **May 31, 2024** |
| Numerator: |  |  |
| Net income (loss) available to common shareholders | $(4594018) | $(4194359) |
| Effect of common stock equivalents |  |  |
| Less: dividends to C preferred shareholders | (12073) |  |
| Net income (loss) adjusted for common stock equivalents | (4606091) | (4194359) |
| Denominator: |  |  |
| Weighted average shares – basic | 15517671159 | 9882118105 |
| Net income (loss) per share – basic | $(0.00) | $(0.00) |
| Denominator: |  |  |
| Weighted average shares – diluted | 15517671159 | 9882118105 |
| Net income (loss) per share – diluted | $(0.00) | $(0.00) |

---

The anti-dilutive shares of common stock equivalents for the three months ended May 31, 2025 and 2024 were as follows:

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** |
|  | **May 31, 2025** | **May 31, 2024\*** |
| Convertible Series F Preferred Shares | 58641215500 | 35600264971 |
| Convertible Redeemable Series B & C Preferred Shares | 295826429 | 59933023 |
| Stock options and warrants | 226177522 | 486251667 |
| Total | 59163219451 | 36146449661 |

---

**15. SUBSEQUENT EVENTS**

Subsequent to May 31, 2025 through to filing date,

the Company issued 800,000,000 common shares pursuant to a share purchase agreement for gross proceeds of $736,000, issuance costs of $40,611 and net proceeds of $695,389.

The Company issued 500,000,000 shares to a lender to settle $575,000 in principal pursuant to exchange agreements with the lender.

on June 11, 2025 the Company entered into an Equity Financing Agreement whereby an investor shall invest up to $30,000,000 over the course of twenty four (24) month at a purchase price of eighty percent (80%) of the lowest trade price in the 9 day preceding period. If the average Closing Price for the Common Stock during the three (3) trading days preceding a purchase is equal to or greater than one cent ($.01) per share, the applicable purchase price shall equal eighty five percent (85%) of the lowest trade price in the 9 day preceding period. Following an up-list to the NASDAQ or an equivalent national exchange by the Company, the purchase price shall equal ninety percent (90%) of the lowest Volume Weighted Average Price ("VWAP") for the Common Stock during the 9 day preceding period subject to a floor of $2.00 per share, below which the Company shall not be required to sell shares. In conjunction with the above agreement, the Company entered into a Registration Rights Agreement. On June 16, 2025 the parties cancelled these agreements.

on June 16, 2025 the Company entered into a new Equity Financing Agreement whereby another investor shall invest up to $30,000,000 over the course of twenty four (24) month at a purchase price of eighty percent (80%) of the lowest trade price in the 9 day preceding period. If the average Closing Price for the Common Stock during the three (3) trading days preceding a purchase is equal to or greater than one cent ($.01) per share, the applicable purchase price shall equal eighty five percent (85%) of the lowest trade price in the 9 day preceding period. Following an up-list to the NASDAQ or an equivalent national exchange by the Company, the purchase price shall equal ninety percent (90%) of the lowest Volume Weighted Average Price ("VWAP") for the Common Stock during the 9 day preceding period subject to a floor of $2.00 per share, below which the Company shall not be required to sell shares. In conjunction with the above agreement, the Company entered into a Registration Rights Agreement.

A settlement agreement entered into with a lender (see Note 11 (13) whereby the Company would pay $420,000 to fully settle outstanding principal and interest of $4,790,185) was subject to court approval which was granted on June 5, 2025. The Company and the estate of the lender have modified the remaining payment schedule. The Company repaid $150,000 in June and will repay the $220,000 remaining balance by August 9, 2025. Upon settlement in August, the Company will record a gain on settlement of debt of $4,370,185.

[**Table of Contents**](#toc_001)

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

***Forward-Looking Statements***

The following discussion of our financial condition and results of operations for the three months ended May 31, 2025 and May 31, 2024 should be read in conjunction with our unaudited consolidated financial statements and the notes to those statements that are included elsewhere in this report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under Item 1A. Risk Factors appearing in our Annual Report on Form 10-K for the year ended February 28, 2025, as filed on May 29, 2025 with the SEC. We use words such as "anticipate," "estimate," "plan," "project," "continuing," "ongoing," "expect," "believe," "intend," "may," "will," "should," "could," and similar expressions to identify forward-looking statements.

Unless expressly indicated or the context requires otherwise, the terms "AITX", the "Company", "we", "us", and "our" refer to Artificial Intelligence Technology Solutions Inc.

***Overview***

AITX was incorporated in Florida on March 25, 2010. AITX reincorporated into Nevada on February 17, 2015. AITX's fiscal year end is February 28 (February 29 during leap year). AITX is located at 10800 Galaxie Ave., Ferndale Michigan, 48220, and our telephone number is 877-767-6268.

AITX's mission is to apply Artificial Intelligence (AI) technology to solve enterprise problems categorized as expensive, repetitive, difficult to staff, and outside of the core competencies of the client organization.

A short list of basic examples include:

&nbsp;&nbsp;&nbsp;&nbsp;1. Typical
 security guard-related functions such as monitoring a parking lot during and after hours and responding appropriately. This scenario
 applies to perimeters, interior yard areas, and related similar environments.

2. Integrated
 hardware/software with AI-driven responses, simulating and expanding on what legacy or manned solutions could perform.

3. Automation
 of common access control functions through technology utilizing facial recognition and machine vision, leapfrogging most legacy solutions
 in use today.

RAD solutions are unique because they:

&nbsp;&nbsp;&nbsp;&nbsp;1. Start
 with an AI-driven autonomous response utilizing cellular-optimized communications, while easily connecting to a human operator for
 a manned response, as needed.

2. Use
 unique hardware purpose-built by RAD for delivery of these solutions. Various form factors have been customized to deliver this new
 functionality.

3. Deliver
 services through RAD-developed software and cloud services, allowing enterprise IT groups to focus on core competencies instead of
 maintenance of complex video and security platforms.

We encourage everyone to ensure they have the most up to date news by visiting AITX at AITX News - AITX - Artificial Intelligence Technology Solutions.

[**Table of Contents**](#toc_001)

***Management Discussion and Analysis***

***Results of Operations for the Three Months Ended May 31, 2025 and 2024***

The following table shows our results of operations for the three months ended May 31, 2025 and 2024. The historical results presented below are not necessarily indicative of the results that may be expected for any future period.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Period** | **Period** | | |
|  | | | **Change** | **Change** |
|  | **Three Months Ended**<br>**May 31, 2025** | **Three Months Ended**<br>**May 31, 2024** | **Dollars** | **Percentage** |
| Revenues | $1854837 | $1182800 | $672037 | 57% |
| Gross profit | 1233501 | 685334 | 548167 | 80% |
| Operating expenses | 4412170 | 3518590 | 893580 | 25% |
| Loss from operations | (3178669) | (2833256) | (345413) | 12% |
| Other income (expense), net | (1415349) | (1361103) | (54246) | 4% |
| Net loss | $(4594018) | $(4194359) | $(399659) | 10% |

---

*Revenue*

The following table presents revenues from contracts with customers disaggregated by product/service:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | | | **Change** | **Change** |
|  | **Three Months Ended**<br>**May 31, 2025** | **Three Months Ended**<br>**May 31, 2024** | **Dollars** | **Percentage** |
| Device rental activities | $1627286 | $980536 | $646750 | 66% |
| Direct sales of goods and services | 227551 | 202264 | 25287 | 13% |
|  | $1854837 | $1182800 | $672037 | 57% |

---

Total revenue for the three-month period ended May 31, 2025 was $1,854,837 which represented an increase of $672,037 or 57% compared to total revenue of $1,182,800 for the three months ended May 31, 2024. Rental activities increased by $646,750 or 66%, as the Company continues to grow its product line and customer base. Direct sales grew by 13% driven by higher training revenue for the three months ended May 31, 2025.

*Gross profit*

Total gross profit for the three-month period ended May 31, 2025 was $1,233,501 which represented an increase of $548,167 compared to gross profit of $685,334 for the three months ended May 31, 2024. The increase is consistent with the increase in revenues as well as changes in product mix. The gross profit % of 67% for the three-month period ended May 31, 2025 compared with the gross profit % of 58% for the three month period ended May 31, 2024. The gross profit % was higher because of higher proportion of rental revenues.

 

*Operating Expenses*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Period** | **Period** | **Change** | **Change** |
|  | **Three Months Ended**<br> **May 31, 2025** | **Three Months Ended**<br> **May 31, 2024** | **Dollars** | **Percentage** |
| Research and development | $1087619 | $810150 | $277469 | 34% |
| General and administrative | 3232211 | 2550751 | 681460 | 27% |
| Depreciation and amortization | 34121 | 95676 | (61555) | (64%) |
| Operating lease cost and rent | 58219 | 62013 | (3794) | (6)% |
| Operating expenses | $4412170 | $3518590 | $893580 | 25% |

---

[**Table of Contents**](#toc_001)

Our operating expenses were comprised of general and administrative expenses, research and development, and depreciation. General and administrative expenses consisted primarily of professional services, automobile expenses, advertising, salaries and wages, travel expenses and consultants. Our operating expenses during the three-month period ended May 31, 2025 and May 31, 2024, were $4,412,170 and $3,518,590, respectively. The overall increase of $893,580 was primarily attributable to the following changes in operating expenses of:

● General and administrative expenses increased by $681,460. In comparing the three months ended May 31, 2025 and May 31, 2024 this increase was primarily due to the following increases: wages and salaries by $388,250, commissions by $43,018, production supplies by $44,308, professional fees by $57,997, marketing by $106,977, and bad debts expenses by $42,066 offset with other net G& A account decreases.

● Research and development increased by $277,469 due to an increase in software development.

● Depreciation and amortization decreased by $61,555 due to fixed assets being fully depreciated in 2025 as well as a lower allocation of revenue earning devices to operating expenses due to a change in estimate based on experience.

● Operating lease cost and rent decreased by $3,794 due to one less lease in 2025.

*Other Income (Expense)*

Other income (expense) during the three months ended May 31, 2025 and May 31, 2024, was ($1,415,349) and ($1,361,103), respectively. The $54,246 increase in other expense was primarily attributable to a $65,000 settlement accrued for as described in Note 13 during the three months ended May 31, 2025.

*Net loss*

We had a net loss of $4,594,018 for the three months ended May 31, 2025, compared to a net loss of $4,194,359 for the three months ended May 31, 2024. The increase in net loss of $399,659 is due to a number of factors: higher research and development and general and administrative expenses is reduced by higher gross profit for the three months ended May 31, 2025.

[**Table of Contents**](#toc_001)

**Liquidity, Capital Resources and Cash Flows**

Management believes that we will continue to incur losses for the immediate future. Therefore, we will need additional equity or debt financing until we can achieve profitability and positive cash flows from operating activities, if ever. These conditions raise substantial doubt about our ability to continue as a going concern. Our unaudited condensed consolidated financial statements do not include and adjustments relating to the recovery of assets or the classification of liabilities that may be necessary should we be unable to continue as a going concern.

As of May 31, 2025, we had a cash balance of $324,847, accounts receivable (net) of $893,694, device parts inventory(net) of $1,511,783 and $7,076,967 in current liabilities. At the current cash consumption rate, we will need to consider additional funding sources going forward. We are taking proactive measures to reduce operating expenses and drive growth in revenue.

The successful outcome of future activities cannot be determined at this time and there is no assurance that, if achieved, we will have sufficient funds to execute our intended business plan or generate positive operating results.

*Capital Resources*

The following table summarizes total current assets, liabilities and working capital (deficit) for the periods indicated:

---

| | | |
|:---|:---|:---|
|  | **May 31, 2025** | **February 28, 2025** |
| Current assets | $3322657 | $5028543 |
| Current liabilities | 7076967 | 7576681 |
| Working capital | $(3754310) | $(2548138) |

---

As of May 31, 2025 and February 28, 2025, we had a cash balance of $324,857 and $865,975, respectively.

*Summary of Cash Flows*

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> May 31, 2025** | **Three Months Ended<br> May 31, 2024** |
| Net cash used in operating activities | $(3321185) | $(3045831) |
| Net cash used in investing activities | $(9720) | $(21728) |
| Net cash (used in) provided by financing activities | $2789777 | $3154736 |

---

***Net cash used in operating activities.***

Net cash used in operating activities for the three months ended May 31, 2025 was $3,321,185 which included a net loss of $4,594,018, non-cash activity such as bad debts expense of $48,982, reduction of right of use asset of $33,865, accretion of lease liability $27,428, stock based compensation of $80,355, change in operating assets and liabilities of $547,338 amortization of debt discount of $47,089, increase in related party accrued payroll and interest of $5,700 and depreciation and amortization of $482,076 to derive the uses of cash in operations.

***Net cash used in investing activities.***

Net cash used in investing activities for the three months ended May 31, 2025 was $9,720 which was the purchase of fixed assets of $8,422 and an acquisition of trademark of $1,298.

***Net cash provided by financing activities.***

Net cash provided by financing activities for the three months ended May 31, 2025 was $2,789,777. This consisted of share proceeds net of issuance costs of 2,839,777 reduced by repayments on loans payable of $50,000.

***Off-Balance Sheet Arrangements***

None.

[**Table of Contents**](#toc_001)

***Critical Accounting Policies and Estimates***

Critical accounting policies and estimates are further discussed in our Annual Report on Form 10-K for the year ended February 28, 2025, as filed on May 29, 2025.

***Related Party Transactions***

For both the three months ended May 31, 2025, and May 31, 2024, the Company had no repayments of net advances from its loan payable-related party. At May 31, 2025, the loan payable-related party was $335,065 and $329,365 at February 28, 2025. Included in the balance due to the related party at May 31, 2025, is $258,533 of deferred salary and interest, $190,013 of which bears interest at 12%. As of February 28, 2025, included in the balance due to the related party is $252,833 of deferred salary and interest, $190,013 of which bears interest at 12%. The accrued interest included in the loan at May 31, 2025, and February 28, 2025, was $57,275, and $51,575, respectively.

During the three months ended May 31, 2025, the Company paid out gross payments to the CEO of $1,496,687 offset by a bonus accrual of $250,000, which yields a net change of $1,246,687 relating to deferred compensation for CEO. This was all in accordance with a December 2023 board action allowing for $1 million of annual discretionary compensation as well as a February 28, 2025, board action which provided an additional $1.5 million in compensation. There were no payments or accruals for the three months ended May 31, 2025, relating to deferred compensation for CEO. The balance of deferred compensation for CEO was $955,913 and $2,202,600 at May 31, 2025, and February 28, 2025, respectively

For the three months ended May 31, 2025, the Company accrued $0 (three months ended May 31 2024-$0) of incentive compensation plan payable to the CEO . This will be payable in Series G Preferred Shares which are redeemable at the Company's option at $1,000 per share. At May 31, 2025, and February 28, 2025, there was $4,000,000 and $4,000,000 of incentive compensation payable.

During the three months ended May 31, 2025, and 2024, the Company was charged $736,875 and $631,584, respectively for fees for research and development from a company partially owned by a principal shareholder. The principal shareholder received no compensation from this partially owned research and development company and the fees were spent on core development projects. As at both May 31, 2025, and February 28, 2025, the balance due to this company was $76,532.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Not applicable for a smaller reporting company.

**ITEM 4. CONTROLS AND PROCEDURES**

**Management's Report on Internal Control over Financial Reporting**

We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of May 31, 2025. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of May 31, 2025, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed by us under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

&nbsp;&nbsp;&nbsp;&nbsp;1. As
 of May 31, 2025, we did not maintain effective controls over our control environment. Specifically, we have not developed and effectively
 communicated to our employees our accounting policies and procedures. This has resulted in inconsistent practices. Further, the Board
 of Directors does not currently have any independent members and no director qualifies as an audit committee financial expert as
 defined in Item 407(d)(5)(ii) of Regulation S-K. Since these entity level programs have a pervasive effect across the organization,
 management has determined that these circumstances constitute a material weakness.

2. As
 of May 31, 2025, we did not maintain effective controls over financial statement disclosure. Specifically, controls were not designed
 and in place to ensure that all disclosures required were originally addressed in our financial statements. Accordingly, management
 has determined that this control deficiency constitutes a material weakness.

Our management, including our principal executive officer and principal financial officer, do not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

[**Table of Contents**](#toc_001)

**PART II — OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

On September 24, 2024, a prospective lender filed a claim against the Company for an alleged breach of a non-binding term sheet made on June 7, 2024. The Company and its counsel believe the claim is without merit however the courts have mandated mediation. After consideration of business factors the parties executed a settlement agreement in June 2025 with the Company agreeing to pay $65,000 with no admission of wrong doing. The Company accrued the $65,000 at May 31, 2025.

**ITEM 1A. RISK FACTORS**

This item is not applicable to smaller reporting companies.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

Each issuance of securities was issued without registration in reliance of the exemption from registration Section 3(a)9 of the Securities Act of 1933.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

The Company has not defaulted upon senior securities.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable to the Company.

**ITEM 5. OTHER INFORMATION**

None.

[**Table of Contents**](#toc_001)

**ITEM 6. EXHIBITS**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description of Document** |
| 3.1 | [Articles of Incorporation (1)](https://www.sec.gov/Archives/edgar/data/1498148/000116169718000118/ex_3-1.htm) |
| 3.2 | [Bylaws (2)](https://www.sec.gov/Archives/edgar/data/1498148/000116169710000728/ex_3-2.htm) |
| 14 | [Code of Ethics (2)](https://www.sec.gov/Archives/edgar/data/1498148/000116169710000728/ex_14-1.htm) |
| 21 | [Subsidiaries of the Registrant (3)](ex21-1.htm) |
| 31.1 | [Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer. (3)](ex31-1.htm) |
| 31.2 | [Rule 13(a)-14(a)/15(d)-14(a) Certification of principal financial and accounting officer. (3)](ex31-2.htm) |
| 32.1 | [Section 1350 Certification of principal executive officer. (3)](ex32-1.htm) |
| 32.2 | [Section 1350 Certification of principal financial accounting officer. (3)](ex32-2.htm) |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. (3) |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document (3) |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document (3) |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document (3) |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document (3) |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document (3) |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) (3) |

---

(1) Incorporated
 by reference to our Form 10-KT file with the Securities and Exchange Commission on March 12, 2018.

(2) Incorporated
 by reference to our Form S-1 filed with the Securities and Exchange Commission on August 4, 2010.

(3) Filed
 or furnished herewith.

[**Table of Contents**](#toc_001)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | Artificial Intelligence Technology Solutions Inc. | Artificial Intelligence Technology Solutions Inc. |
| Date: July 15, 2025 | BY: | */s/ Steven Reinharz* |
|  |  | Steven Reinharz |
|  |  | President, Chief Executive Officer (principal executive officer) |
| Date: July 15, 2025 | BY: | */s/ Anthony Brenz* |
|  |  | Anthony Brenz |
|  |  | Chief Financial Officer (principal financial officer) |

---

## Exhibit 21.1

**Exhibit 21.1**

**Artificial Intelligence Technology Solutions Inc.**

**Subsidiaries**

---

| | |
|:---|:---|
| **Name** | **Jurisdiction of Incorporation** |
| Robotic Assistance Devices, Inc. | Nevada |
| Robotic Assistance Devices Group, Inc. | Nevada |
| Robotic Assistance Devices Mobile, Inc. | Nevada |
| Robotic Assistance Devices Residential, Inc. | Nevada |

---

Robotic Assistance Devices Lanka (Private) Limited Sri Lanka

## Exhibit 31.1

**Exhibit 31.1**

**RULE 13A-14(A)/15D-14(A) CERTIFICATION**

I, Steven Reinharz, certify that:

1. I have reviewed this Form 10-Q for the period ended May 31, 2025 of Artificial Intelligence Technology Solutions Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15-d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: July 15, 2025 | BY: | */s/ Steven Reinharz* |
|  |  | Steven Reinharz |
|  |  | President, Chief Executive Officer (principal executive officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**RULE 13A-14(A)/15D-14(A) CERTIFICATION**

I, Anthony Brenz, certify that:

1. I have reviewed this Form 10-Q for the period ended May 31, 2025 of Artificial Intelligence Technology Solutions Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15-d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: July 15, 2025 | BY: | */s/ Anthony Brenz* |
|  |  | Anthony Brenz |
|  |  | Chief Financial Officer (principal financial officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**SECTION 1350 CERTIFICATION**

In connection with the quarterly report of Artificial Intelligence Technology Solutions Inc. (the "Company") on Form 10-Q for the period ended May 31, 2025 as filed with the Securities and Exchange Commission (the "Report"), I, Steven Reinharz, President of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The
 Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The
 information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of
 the Company.

---

| | | |
|:---|:---|:---|
| Date: July 15, 2025 | BY: | */s/ Steven Reinharz* |
|  |  | Steven Reinharz |
|  |  | President, Chief Executive Officer (principal executive officer) |

---

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 32.2

**Exhibit 32.2**

**SECTION 1350 CERTIFICATION**

In connection with the quarterly report of Artificial Intelligence Technology Solutions Inc. (the "Company") on Form 10-Q for the period ended May 31, 2025 as filed with the Securities and Exchange Commission (the "Report"), I, Anthony Brenz, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The
 Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The
 information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of
 the Company.

---

| | | |
|:---|:---|:---|
| Date: July 15, 2025 | BY: | */s/ Anthony Brenz* |
|  |  | Anthony Brenz |
|  |  | Chief Financial Officer (principal financial officer) |

---

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.